A Randomized Clinical Trial of Alcohol Care Management
Launched by US DEPARTMENT OF VETERANS AFFAIRS · Jan 5, 2007
Trial Information
Current as of April 28, 2025
Completed
Keywords
ClinConnect Summary
Background: Alcohol dependence is one of the leading causes of disability worldwide. Despite the availability of efficacious treatments less than 20% of individuals with alcohol dependence are actively engaged in treatment. Within the VA system systematic screening was implemented to increase the identification of patients with both abuse and dependence. However, there continues to be a marked discrepancy in the care offered or accessed among those identified with alcohol dependence. Existing treatment guidelines suggest that all persons with dependence receive care in specialty addiction t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • be men and women = 18 years of age;
- • meet criteria for alcohol dependence;
- • drink more than an average of 2 drinks per day prior to study entry (over the last 60 days);
- • have adequate hearing to participate in assessment
- Exclusion Criteria:
- • show no evidence of current abuse or dependence of illicit substances other than marijuana;
- • no current hallucinations;
- • no current symptoms of mania;
- • be relatively cognitively intact
- • not actively participate in specialized addition or behavioral health treatment within the prior 12 months
About Us Department Of Veterans Affairs
The U.S. Department of Veterans Affairs (VA) is a federal agency dedicated to serving the needs of America’s veterans through comprehensive healthcare services, support programs, and research initiatives. As a clinical trial sponsor, the VA focuses on advancing medical knowledge and improving treatment outcomes for veterans by conducting rigorous scientific studies. The VA leverages its extensive network of medical facilities and experienced healthcare professionals to facilitate innovative research, particularly in areas relevant to veteran populations, including mental health, chronic conditions, and rehabilitation. By prioritizing veteran health and well-being, the VA aims to enhance the quality of care and contribute to the broader medical community's understanding of health issues affecting veterans.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Syracuse, New York, United States
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
David W. Oslin, MD
Principal Investigator
Philadelphia VA Medical Center, Philadelphia, PA
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials